Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
Request a FREE Sample of our FcRn Binding Kit!
Request a FREE Sample of our Fc gamma RI / CD64 Binding Kit !
Happy Holiday! Limited Keychain here with your next orderHappy Holiday! Limited Keychain here with your next order
Request a FREE sample of our GMP products! Request a FREE sample of our GMP products!
| Cat. No. | Species | Product Description | Structure | Purity | Feature |
|---|---|---|---|---|---|
| PGN-H52H3 | Human | Human Progranulin Protein, His Tag, low endotoxin (MALS & SPR verified) |  |
|
|
Biotinylated Human Sortilin Protein, His,Avitag (Cat. No. SON-H82E9) captured on Biotin CAP-Series S Sensor Chip can bind Human Progranulin Protein, His Tag (Cat. No. PGN-H52H3) with an affinity constant of 0.355 μM as determined in a SPR assay (Biacore 8K) (QC tested).
The purity of Human Progranulin Protein, His Tag (Cat. No. PGN-H52H3) is more than 90% and the molecular weight of this protein is around 75-95 kDa verified by SEC-MALS.
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| GRN Gene Therapy（Eli Lilly And Company） | PR-006 | Phase 2 Clinical | Eli Lilly And Company | Frontotemporal Dementia | Details |
| DNL-593 | DNL-593; PTV:PGRN | Phase 2 Clinical | Denali Therapeutics Inc | Frontotemporal Dementia | Details |
| AVB-101 | AVB-101 | Phase 2 Clinical | AviadoBio Ltd | Frontotemporal Dementia | Details |
| AL-101 | GSK-4527226; AL-101 | Phase 2 Clinical | Alector Inc | Nerve Degeneration; Alzheimer Disease; Parkinson Disease; Frontotemporal Dementia; Amyotrophic Lateral Sclerosis | Details |
| PBFT-02 | PBFT-02 | Phase 2 Clinical | Passage Bio Inc | Frontotemporal Dementia | Details |
| AG-01（A&G Pharm） | AG-01（A&G Pharm） | Phase 1 Clinical | A&G Pharmaceutical | Triple Negative Breast Neoplasms; Mesothelioma; Carcinoma, Non-Small-Cell Lung | Details |
| GRN Gene Therapy（Eli Lilly And Company） | PR-006 | Phase 2 Clinical | Eli Lilly And Company | Frontotemporal Dementia | Details |
| DNL-593 | DNL-593; PTV:PGRN | Phase 2 Clinical | Denali Therapeutics Inc | Frontotemporal Dementia | Details |
| AVB-101 | AVB-101 | Phase 2 Clinical | AviadoBio Ltd | Frontotemporal Dementia | Details |
| AL-101 | GSK-4527226; AL-101 | Phase 2 Clinical | Alector Inc | Nerve Degeneration; Alzheimer Disease; Parkinson Disease; Frontotemporal Dementia; Amyotrophic Lateral Sclerosis | Details |
| PBFT-02 | PBFT-02 | Phase 2 Clinical | Passage Bio Inc | Frontotemporal Dementia | Details |
| AG-01（A&G Pharm） | AG-01（A&G Pharm） | Phase 1 Clinical | A&G Pharmaceutical | Triple Negative Breast Neoplasms; Mesothelioma; Carcinoma, Non-Small-Cell Lung | Details |
This web search service is supported by Google Inc.
A-Z
